Hepatic Adenoma

Hepatic adenoma is a rare, benign tumor that develops in the liver, which is a vital organ responsible for many functions including detoxification and metabolism. These tumors are often linked to the use of oral contraceptives or anabolic steroids and mostly affect young women. Although usually asymptomatic, they can cause abdominal pain or discomfort if they grow large. A major concern with hepatic adenomas is the risk of bleeding inside the tumor or, rarely, transformation into liver cancer. Diagnosis often involves imaging tests like ultrasound or MRI to visualize the tumor. Understanding this condition helps in monitoring and managing potential complications.

Hepatic adenoma is a benign monoclonal neoplasm of hepatocytes typically arising in the setting of hormonal stimulation, especially from estrogen exposure such as oral contraceptives or anabolic steroids. It is characterized by well-circumscribed, non-encapsulated lesions composed of hepatocytes without normal portal tracts or bile ducts. The tumor is significant due to its potential for spontaneous hemorrhage and rare malignant transformation into hepatocellular carcinoma. It predominantly affects young women and is often discovered incidentally or during evaluation for abdominal pain. Molecular subtypes include those with mutations in HNF1A, CTNNB1, or inflammatory markers, which influence clinical behavior. Imaging and histopathology are essential for diagnosis and differentiation from other liver lesions.